ZVSA
USDZyVersa Therapeutics Inc. Common Stock
$0.145+0.009 (6.618%)
Real-time Price
Healthcare
Biotechnology
United States
Price Chart
Loading Chart...
Key Metrics
Market Metrics
Open
$0.136
High
$0.145
Low
$0.136
Volume
0.00M
Company Fundamentals
Market Cap
1.2M
Industry
Biotechnology
Country
United States
Trading Stats
Avg Volume
0.04M
Exchange
OQB
Currency
USD
52-Week Range
Low $0.11Current $0.145High $1.95
Related News
GlobeNewswire
ZyVersa Therapeutics Highlights Data Reinforcing the Potential of Inflammasome Inhibitors to Attenuate Progression of Type 2 Diabetes and Improve Associated Long-term Cardiovascular Outcomes
Type 2 diabetes (T2DM), affecting more than 530 million worldwide, is a metabolic disease often coupled with cardiovascular complications including coronary artery disease, heart failure, and stroke.Cardiovascular
View more
GlobeNewswire
ZyVersa Therapeutics Highlights Lipidomic Data in Alport Syndrome and DKD Reinforcing the Need for Drugs to Attenuate Damaging Renal Lipid Accumulation to Mitigate Disease Progression
ZyVersa is developing Cholesterol Efflux Mediator™ VAR 200 to mediate removal of damaging excess cholesterol and other lipids from the kidneys' filtration system. VAR 200 directly removes lipids from kidney cells,
View more
Related Stocks
Stay Updated
Set price alerts, get AI analysis updates and real-time market news.